These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37932138)

  • 1. [Chinese expert consensus on neoadjuvant therapy for hepatocellular carcinoma (2023 edition)].
    ; ;
    Zhonghua Wai Ke Za Zhi; 2023 Dec; 61(12):1035-1045. PubMed ID: 37932138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma.
    Zhao HT; Cai JQ
    World J Gastroenterol; 2021 Dec; 27(47):8069-8080. PubMed ID: 35068855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.
    Samuel M; Chow PK; Chan Shih-Yen E; Machin D; Soo KC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD001199. PubMed ID: 19160192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status and challenges of neoadjuvant immunotherapy for hepatocellular carcinoma].
    Xia YX; Cao HS; Tang WW; Wang XH
    Zhonghua Wai Ke Za Zhi; 2023 Jan; 61(1):7-12. PubMed ID: 36603877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese multidisciplinary expert consensus on combined immunotherapy for hepatocellular carcinoma(2023 version)].
    ; ;
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):16-34. PubMed ID: 36948846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in perioperative systemic therapy for hepatocellular carcinoma].
    Bai XL; Jia L; Liang TB
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):741-744. PubMed ID: 32993258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of neoadjuvant immunotherapy for hepatocellular carcinoma].
    Xia YX; Zhang H; Zhang F; Li XC; Rong DW; Tang WW; Cao HS; Zhao J; Wang P; Pu LY; Qian XF; Cheng F; Wang K; Kong LB; Zhang CY; Li DH; Song JH; Yao AH; Wu XF; Wu C; Wang XH
    Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):688-694. PubMed ID: 35775262
    [No Abstract]   [Full Text] [Related]  

  • 9. Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).
    Yang Y; Sun J; Wu M; Lau WY; Zheng S; Wang XH; Chen X; Fan J; Dong J; Cai J; Chen M; Chen Y; Cheng Z; Dai C; Shan J; Du CY; Fang C; Hu H; Ji Z; Jia W; Li G; Li J; Li J; Liu C; Liu F; Ma Y; Mao Y; Niu Z; Shen J; Shi J; Shi X; Song W; Sun HC; Tan G; Tao R; Wang X; Wen T; Wu L; Xia J; Xiang BD; Yan M; Ying M; Zhang L; Zhang X; Zeng ZC; Zhang Y; Zhang Z; Zhou J; Zhou C; Zhou J; Zhou L; Zhou X; Zhu J; Zhu Z; Zhang Q; Li Q; Cheng S
    Liver Cancer; 2022 Dec; 11(6):511-526. PubMed ID: 36589726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma.
    Zhang B; Yue J; Shi X; Cui K; Li L; Zhang C; Sun P; Zhong J; Li Z; Zhao L
    BMJ Open; 2022 Sep; 12(9):e060955. PubMed ID: 36115673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlook.
    Sahin IH; Khalil L; Millett R; Kaseb A
    Chin Clin Oncol; 2021 Feb; 10(1):7. PubMed ID: 33440948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition).
    Liu X; Lu Y; Zhou W; Peng T; Zhou J; Bi H; Xia F; Chen X
    Liver Cancer; 2024 Aug; 13(4):355-375. PubMed ID: 39114757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study.
    Woei-A-Jin FJSH; Weijl NI; Burgmans MC; Fariña Sarasqueta A; van Wezel JT; Wasser MNJM; Coenraad MJ; Burggraaf J; Osanto S
    Oncologist; 2021 Oct; 26(10):854-864. PubMed ID: 34251745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma(2024 edition)].
    ; ;
    Zhonghua Wai Ke Za Zhi; 2024 Nov; 62(11):984-995. PubMed ID: 39394621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.
    Wang Z; Zhang G; Wu J; Jia M
    Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery and transplantation for hepatocellular cancer.
    Wall WJ; Marotta PJ
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors.
    Arita J; Ichida A; Nagata R; Mihara Y; Kawaguchi Y; Ishizawa T; Akamatsu N; Kaneko J; Hasegawa K
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):732-740. PubMed ID: 35306748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
    Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
    Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapies for hepatocellular carcinoma.
    Ge S; Huang D
    Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence.
    Andreana L; Burroughs AK
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S249-57. PubMed ID: 20547311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.